Fate Therapeutics has appointed Bob Valamehr to succeed Scott Wolchko as chief executive, effective a Jan. 1. The clinical-stage biopharmaceutical company on Friday said that Valamehr has headed the ...
U.S. stocks finished off their best monthly performance in a year on Friday, with the Dow and S&P 500 clinching fresh record closing highs to cap off a blockbuster November. Major indexes from the S&P ...
The Dow looks poised to close above 45,000 for the first time ever when the bell rings Friday on an abbreviated session, but as MarketWatch's Isabel Wang notes, the blue-chip gauge's 1,000-point ...
The Dow Jones Industrial Average has tallied a major milestone on an otherwise quiet day for markets, topping 45,000 for the first time. The threshold was crossed just a few minutes ago as stocks ...
On the macroeconomic front, Canada's economy lost some momentum in the third quarter, slowing to a 1% growth rate, thanks to lower business investment and exports. Analysts think this tepid ...
U.S. stocks hit session highs just before noon on Friday, with both the Dow and S&P 500 poised for another round of record closes -- while the blue-chip average also stood on the cusp of a major ...